Share on LinkedInShare on LinkedIn

ARTICLE · 01 JUNE 2021

COVID-19 Key EU Developments, Policy & Regulatory Update No. 48

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

European UnionCoronavirus (COVID-19)

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

COMPETITION & STATE AID

Competition

Multilateral Working Group on pharmaceutical company mergers launches a joint public consultation (see here)

On 10 May 2021, the Multilateral Pharmaceutical Merger Task Force launched a joint public consultation in the field of pharmaceutical company mergers.

Created in March 2021, the Task Force brings together the European Commission's Directorate General for Competition, the Canadian Competition Bureau, the UK's Competition and Markets Authority, the U.S. Federal Trade Commission ("FTC"), the U.S. Department of Justice and three Offices of Attorneys General (see also Jones Day COVID-19 Update No. 40 of 17 March 2021).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from